According to a study published in the European Heart Journal there has been a reduction of risk of dementia in persons who are taking blood-thinning medication. Originally intended to prevent strokes, researchers have found that those who are taking these anticoagulants, developed dementia 29 percent less of the time. These findings were derived from over 440,000 persons in Sweden who were taking blood-thinning medication due to a variety of reasons, including those who are living atrial fibrillation, and other abnormal heart conditions. The study would be the largest ever that looked at the link between anticoagulants and persons living with dementia and atrial fibrillation. Clinical trials will be necessary to the establish a cause and effect relationship, but would be ethically impossible due to the fact that you cannot give persons living with these conditions a placebo and then wait for them to develop dementia or have a stroke occur. It is theorized that the anticoagulants help in the prevention of the development of dementia by thinning the blood so that microscopic clots do not form, that would otherwise cause tiny strokes that lead to cognitive decline.
SOURCE: CTV News October 25th, 2017
ORIGINAL SOURCE: European Heart Journal
DATE RETRIEVED: October 31st, 2017